Concepedia

Daniel Heinzelmann

DH

Statistics

Publications

2

Citations

30

H-Index

2

Active since

2023

Affiliations

Boehringer Ingelheim (Germany)(Current)

Daniel Heinzelmann is an author at Boehringer Ingelheim (Germany) specializing in genome editing, crispr-cas9 validation, and biotechnology.

ORCID

Publications per year

2023–2024

2

Publications

2

Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations

Melanie Maier, Linus Weiß, Nikolas Zeh et al. · mAbs · 2024 · 17 citations · Full text

, , +17

Deciphering integration loci of CHO manufacturing cell lines using long read nanopore sequencing

Christian Clappier, Dennis Böttner, Daniel Heinzelmann et al. · New Biotechnology · 2023 · 13 citations · Full text

, , +15

1–2 of 2